Literature DB >> 19220417

AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib.

Prithviraj Bose, Christopher Thompson, Darshan Gandhi, Bassam Ghabach, Howard Ozer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19220417     DOI： 10.1111/j.1600-0609.2009.01235.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  12 in total

Review 1.  Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.

Authors:  Jia-Zhu Wu; Ke Min; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.

Authors:  Yusuke Koizumi; Tomoko Uehira; Yasunori Ota; Yoshihiko Ogawa; Keishiro Yajima; Junko Tanuma; Mihoko Yotsumoto; Shotaro Hagiwara; Satoshi Ikegaya; Dai Watanabe; Hitoshi Minamiguchi; Keiko Hodohara; Kenta Murotani; Hiroshige Mikamo; Hideho Wada; Atsushi Ajisawa; Takuma Shirasaka; Hirokazu Nagai; Yoshinori Kodama; Tsunekazu Hishima; Makoto Mochizuki; Harutaka Katano; Seiji Okada
Journal:  Int J Hematol       Date:  2016-09-07       Impact factor: 2.490

Review 3.  Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies.

Authors:  Erin G Reid
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

4.  Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.

Authors:  Santiago Montes-Moreno; Ana-Rosa Gonzalez-Medina; Socorro-María Rodriguez-Pinilla; Lorena Maestre; Lydia Sanchez-Verde; Giovanna Roncador; Manuela Mollejo; Juan F García; Javier Menarguez; Carlos Montalbán; M Carmen Ruiz-Marcellan; Eulogio Conde; Miguel A Piris
Journal:  Haematologica       Date:  2010-04-23       Impact factor: 9.941

5.  Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

Authors:  Jorge J Castillo; Eric S Winer; Dariusz Stachurski; Kimberly Perez; Melhem Jabbour; Cannon Milani; Gerald Colvin; James N Butera
Journal:  Oncologist       Date:  2010-02-18

6.  Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.

Authors:  Nivedita Arora; Arjun Gupta; Navid Sadeghi
Journal:  BMJ Case Rep       Date:  2017-10-09

7.  Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.

Authors:  Bhagirathbhai Dholaria; Daisy Alapat; Tarun Pandey; Abhishek Agarwal
Journal:  Med Oncol       Date:  2012-05-06       Impact factor: 3.064

Review 8.  Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

Authors:  Ghaleb Elyamany; Eman Al Mussaed; Ali Matar Alzahrani
Journal:  Adv Hematol       Date:  2015-08-18

9.  Human immunodeficiency virus-negative plasmablastic lymphoma in the neck: a rare case report and literature review.

Authors:  Pengli Jiang; Min Liu; Bailong Liu; Bin Liu; Yuhua Zhou; Lihua Dong
Journal:  Eur J Med Res       Date:  2014-11-22       Impact factor: 2.175

10.  A striking response of plasmablastic lymphoma of the oral cavity to bortezomib: a case report.

Authors:  Makoto Hirosawa; Hiroaki Morimoto; Ryo Shibuya; Shohei Shimajiri; Junichi Tsukada
Journal:  Biomark Res       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.